TCL Archive Also NSABP’s STAR Trial Finds Raloxifene Equivalent To Tamoxifen For Breast Cancer Risk Reduction. April 21, 2006
TCL Archive FDA Committee Can’t Find “Reasonable” Evidence Alkylating Agent Clinical Use Is Carcinogenic September 10, 1976
TCL Archive Book Review: In Memoir Written to Avoid Doing Time, Disgraced Exec Reflects on BMS Heyday July 6, 2012
